:max_bytes(150000):strip_icc()/healthdotcom_social_placeholder-e308c2f4262d4313973d6f5e089bba92.png?ssl=1 "MAFLD against Mash: What is the difference?")
| MAFLD | mash | |
| Symptoms similar to influenza | Fatigue and weakness | Nausea and vomiting |
| Stomach symptoms | Pain in the upper abdomen and bloating | Ascites (the accumulation of liquid in the abdomen) |
| Neurological symptoms (brain) | Sleep disturbances | confusion |
| Other symptoms | Excessive thirst | Easy bruises or bleeding, jaundice (yellow eyes and skin), and severe itchy skin |
Malfd occurs when there is an accumulation of fat in the liver, and the mash is a later stage of MAFLD. Although Mash is developing from MAFLD, the two conditions have several differences:
gravity
MAFLD: This type of liver disease leads to the accumulation of fat in the liver. The early stages of this condition are light compared to the subsequent stages.
mash: This is a more severe stage of MAFLD symptoms, while increasing the accumulation of fat in the liver. Additional symptoms include inflammation (swelling) and liver damage.
Possible complications
MAFLD: If you leave without treatment, MAFLD can become more severe and turn into a shell. About 20-30 % of MAFLD cases turn into mash, although the exact cause is unknown.
mash: The non -therapist can cause fibrosis, which can advance to cirrhosis. Liver fibrosis occurs when healthy liver tissue turns into a scar tissue, which prevents the liver from working properly.
As liver fibrosis exacerbates, high blood pressure (high blood pressure that affects blood flow to the abdominal organs), jaundice (yellowing of the skin and eyes), and Hepatic encephalopathy (Toxin accumulates in the brain, causing confusion or difficulty thinking).
Non -therapist cirrhosis may eventually lead to liver failure or Liver cancer (HCC), a type of liver cancer and the main cause of liver transplants. MAFLD will not turn into cirrhosis and liver failure unless it advances to the mash.
Various treatment options
MAFLD: There are no approved drugs from the Food and Drug Administration (FDA) currently available for MAFLD treatment. MAFLD treatment options focus on lifestyle changes such as maintaining weight that you and the optimal health care provider for you, exercising, avoiding alcohol, and eating a balanced diet.
mash: The US Food and Drug Administration (FDA) agreed to a drug, Remeetirom, to treat mild or severe fibrosis. Rezdifra works by lowering the accumulation of fat in the liver. Health care providers recommend taking this medicine as well as a healthy diet and regular exercise to increase its effectiveness and the development of slow disease.
However, for helicopter cases with cirrhosis, liver transplant surgery may be the only option for treatment to restore liver function.
MAFLD and Mash shares many similarities. Understanding these similarities can help early detection and prevent the development of the disease.
Change the lifestyle of the symptoms
Your health care provider may recommend lifestyle changes that can improve MAFLD and Mash.
Some strategies include symptoms:
- Maintaining the weight discussed with your provider
- Eat a balanced diet
- Regularly
- Reducing sugar
- Avoid saturated fats in meat, poultry skin, some milk products and dairy products
Risk factors
Since Mash is a more advanced stage than MAFLD, both conditions share common risk factors.
These risk factors include:
- obesity
- High cholesterol (fatty substance found in the liver and intestine)
- Type 2 diabetes
- Metabolic syndrome (features and conditions associated with obesity)
Diagnostic approach
Health care providers may try to diagnose MAFLD and escape similar by reviewing your medical history and conducting a physical examination to verify symptoms and diagnostic tests.
During your exam, your provider may ask you about:
- Your diet
- The medications you are currently taking
- Other health conditions that you have and that may increase the risk of MAFLD or mash
Some tests that can help diagnose both conditions include blood tests, such as liver function tests (to see the extent of your liver work), photography tests such as ultrasound, CT (CT) or MRI.
You can’t have MAFLD and Mash at the same time because Mash is a more severe stage than MAFLD.
Health care providers diagnose MAFLD based on the accumulation of fat in the liver. If left without treatment, MAFLD can turn into a shell, causing additional symptoms such as swelling and liver damage. Unconscious mash may advance to liver fibrosis, which can also lead to liver failure.
If you begin to suffer from MAFLD or MASH symptoms, you may want to contact the liver specialist (a doctor who specializes in diagnosing and treating liver conditions).
Symptoms may include:
- Extreme fatigue
- nausea
- Vomiting
- Abdominal pain
- Jaundice
- Easy bleeding or bruises
If you have already been diagnosed with the condition of the liver, you must follow regularly with the liver specialist to monitor your condition. You should also communicate if the symptoms do not improve after treatment.
MAFLD and Mash are the liver conditions that cause the accumulation of fat in the liver. Hormones are often advanced from MAFLD, causing inflammation and damage to the liver.
Both cases have similar risk factors and diagnostic steps.
If you suffer from symptoms of liver disease, a The liver specialist can help diagnose your specific condition and recommend the appropriate treatment curricula.